Not So Different: A Podcast from The Center for Biosimilars

S6 Ep16: Biosimilars Business Roundup For August 2023– Podcast Edition

Listen

Description


Show Notes



FDA Approves First MS Biosimilar



Stelara and Enbrel Chosen for IRA Price Negotiation



Biocon Biosimilar Quarterly Sales Up 106%



STADA Earnings Project Record Breaking Profits for 2023



Despite Global Increase in Amjevita Sales, US Sales Dropped 63%



Authors Suggest Major Policy Shifts to Boost Biosimilar Development, Accessibility



Cardinal Health Exec: How Adalimumab Biosimilars Can Reshape the US Health Care Industry